Mesa Laboratories INC /CO/ 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Mesa Laboratories, a global leader in life sciences tools, reported an 11.5% increase in total revenues for fiscal year 2025, driven by organic growth and the GKE acquisition, while successfully managing its debt obligations and remediating prior year internal control weaknesses.
NASDAQ
Mesa Laboratories Inc. releases its annual 10-K filing, outlining its business strategy, segment performance, and financial results for the fiscal year ended March 31, 2024.